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Background: Non-typhoidal Salmonella (NTS) is a public health problem worldwide and particularly in Africa with high
disease burden. This study characterized Salmonella isolates from humans in Ghana to determine serovar distribution,
phage types, and antimicrobial resistance. Further, the clonal relatedness among isolates was determined.
Methods: One hundred and thirty-seven Salmonella isolates (111 clinical and 26 public toilet) were characterized using
standard serotyping, phage typing, and antimicrobial susceptibility testing methods. The molecular
epidemiology of common serovars (Salmonella Typhimurium and Salmonella Enteritidis) was established by pulsed
field gel electrophoresis (PFGE).
Results: Twenty-two serovars were identified with S. Enteritidis, S. Typhimurium, and Salmonella Derby as the most
dominant. One hundred and twelve isolates showed resistance to more than one antimicrobial. Fifty-eight (n = 58/112;
54.5%) strains were multi-resistant with low resistance to cephalosporins ceftazidime (8.0%), cefotaxime (4.5%),
and cefoxitin (2.7%) with synergy to clavulanic acid indicating possible ESBLs. Isolates showed high resistance
to trimethoprim (66.1%), tetracycline (61.6%), ampicillin (57.1%), sulfamethoxazole (46.4%), chloramphenicol (33.9%), and
ciprofloxacin (25.0%). The most common resistance pattern of multi-resistant serovars was to ampicillin, chloramphenicol,
sulphonamide, and trimethoprim. S. Enteritidis (18/43) strains reacted with typing phages but did not conform to any
phage type with PT14B and PT4 as predominant definitive phage types. Six S. Typhimurium strains reacted but did not
conform to any recognized phage type while seven were non-typable. The predominant definitive phage types were
DT1 and DT22. PFGE patterns of human S. Enteritidis were closely related to patterns of poultry isolates obtained in a
previous study in Ghana.
Conclusions: Cephalosporin resistance is uncommon among Salmonella from humans in Ghana. Poultry may be an
important source of human salmonellosis. There is an urgent need for the implementation of routine surveillance of
antimicrobial use and bacterial resistance among humans in Ghana.
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Non-typhoidal Salmonella (NTS) causes a high
disease burden and a considerable number of deaths
globally [1]. They are a leading cause of bacterial
food-borne disease outbreaks and human gastroenter-
itis in developed countries and also a worry to public
health in developing countries [1–3]. These medically
important Gram-negative bacteria are a diverse group* Correspondence: adal@sund.ku.dk
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sion from this source can cause disease in humans [4]. In
developed counties, NTS have been reported to mostly
cause a self-limiting diarrheal illness in healthy individuals
[5]. However, in sub-Saharan Africa, NTS is also a
common pathogen isolated from the blood of both adults
and children presenting with fever [1, 5–8]. NTS is known
to have a fatality rate of 20–25% particularly in immune-
compromised people [7]. Such cases are often mistaken as
fever due to malaria; however, evidence now suggests that
bacterial bloodstream infections accounts for most fevers
of unknown etiology [9, 10]. Several investigations ofle is distributed under the terms of the Creative Commons Attribution 4.0
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a main source of human salmonellosis [11, 12]. Insuffi-
cient potable water supply and poor sanitation are also
risk factors for food- and water-borne diseases associated
with Salmonella serovars in developing countries.
In Ghana, 44.6% of poor households, particularly in
urban areas, use public toilets with no hand washing fa-
cilities [13, 14]. The immediate surroundings of such toi-
lets are also often polluted with both fecal and solid
waste [13, 14]. On average, 1500 persons have been esti-
mated to visit such toilets daily [13]. Salmonella has fre-
quently been isolated from environmental sources that
could serve as a link in its spread between different hosts
[15]. The number of people sharing sanitation facilities
among the poor creates unsanitary conditions and exposes
the poor, children, and the immune-compromised to in-
fectious diseases. In contrast to more developed countries,
where food is mostly the main source of salmonellosis,
direct human to human transmission is of more import-
ance in less developed countries [16]. Pant and Mittal [17]
reported 100% frequency of occurrence of Salmonella in
fecal sludge at all stages of sewage treatment in Delhi,
India. Similarly, the Ghana Health Service has indicated
that about 80% of all out-patient department (OPD) cases
such as cholera, typhoid, and diarrhea are sanitation and
water related [18].
Over the years, reports around the world have shown
S. Typhimurium and S. Enteritidis as the most common
NTS serovars isolated from patients attending hospitals
[19–22]. In Ghana, Salmonella Typhi has been reported
as the predominant Salmonella serovar from blood-
stream infections [6, 23]. The definitive phage type 1
(DT1) of S. Typhi has been identified in isolates from
different geographical locations, indicating a possible
clonal spread of this phage type within Ghana [6]. Infec-
tions due to NTS serovars are also a health problem in
Ghana, with serovar Enteritidis and Typhimurium com-
monly isolated [6, 19, 24]. However, information on the
sources, routes of transmission, serovar diversity in
humans, and the zoonotic potential of Salmonella preva-
lence among food animals is still limited in Ghana, as in
other developing countries, due to the lack of efficient epi-
demiological surveillance systems.
Non-typhoidal Salmonella infections mostly present
with mild-to-moderate self-limiting gastroenteritis and
antimicrobial treatment are only required in severe cases
in immuno-compromised patients or invasive infections.
However, due to increasing resistance of Salmonella to
conventional antimicrobial agents, e.g., ampicillin and
trimethoprim/sulfamethoxazole, used in the treatment of
salmonellosis, amoxicillin/clavulanate, fluoroquinolones,
and third-generation cephalosporins are now increas-
ingly used. In Ghana, the Ghana Health Service recom-
mends the use of chloramphenicol and ciprofloxacin asfirst-line drugs of choice for the treatment of invasive
Salmonella infections, but in areas with multi-
antimicrobial resistance (MAR), third-generation cephalo-
sporins like cefotaxime or ceftriaxone as well as chloram-
phenicol or a fluoroquinolone are recommended. Lately,
treatment with fluoroquinolones or third-generation
cephalosporins has become common practice since ampi-
cillin and cotrimoxazole have become ineffective due to
resistance [6, 21, 23, 25].
In recent years, strains of Salmonella resistant to anti-
microbial drugs have spread worldwide with isolates re-
sistant to quinolones being reported with increasing
frequency in several African countries [26–28]. In Ghana,
earlier reports have indicated the presence of Salmonella
strains showing multi-resistance to antimicrobials rou-
tinely used as therapeutic agents [24]. Of particular con-
cern is the development of resistance to fluoroquinolones
and extended-spectrum β-lactamses (ESBL) [29, 30] which
may have been used either for prophylaxis, therapeutic
treatment of humans, or as growth promoters in livestock
feed. In Ghana, little is known about ESBL-producing
Salmonella serovars.
The objective of the current study was to determine
the serovar distribution of Salmonella from humans in
Ghana, their phage types, and antimicrobial resistance.
Further, the clonal relatedness of strains of the most
common serovars was determined by pulse field gel elec-
trophoresis (PFGE) and patterns compared to patterns
of Salmonella isolates from poultry, which was the only
food animal for which reliable Salmonella typing data
were available in the country.
Methods
Salmonella strains collection
Presumptive positive Salmonella spp. isolates were col-
lected from the central laboratory of the country’s largest
referral hospital, Korle-Bu Teaching Hospital in the capital
of Accra, and a hospital at the Kwame Nkrumah University
of Science and Technology (KNUST) in Kumasi located
northeast of Accra. The inclusion criteria was patients
aged day 1 and above, patients with suspected septi-
cemia or diarrhea, patients with bacteriologically con-
firmed Salmonella infection, or those presenting stool
to the laboratory for examination.
Fecal sludge samples for Salmonella spp. analysis were
collected from 12 public toilets located in three urban
slum areas of Kumasi. These three urban settlements
were selected because of their high poverty, poor and
overcrowded housing, poor sanitation facilities, lack of
access to quality health care, and inadequate manage-
ment of large volumes of municipal solid waste [13].
Further, sampling fecal sludge from public toilets is also
a cost-effective and convenient way of obtaining human
Salmonella isolates. About 50 g of fecal sludge was
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cility with a sterile plastic spoon and placed into labeled
sterile plastic bags and transported to the laboratory in
an ice chest with ice packs.
A total of 137 Salmonella isolates including 111 human
clinical isolates and 26 isolates recovered from sludge col-
lected from public toilets. The 111 human clinical isolates
were recovered from blood (33) and stool (14) of patients
seen at the Korle-Bu Teaching hospital in Accra and the
University hospital in Kumasi between 2010 and 2011.
The additional clinical isolates were 64 Salmonella isolates
recovered from human blood/stool samples (specific
source of origin unknown) between 2007 and 2009 at the
Korle-Bu Teaching hospital.
Isolation of Salmonella strains
Blood culture
Two milliliters of venous blood sample taken from pa-
tients was inoculated into 20 ml brain-heart infusion
broth (BHI) (CM1135; Oxoid Ltd., England, UK). The cul-
ture bottles were incubated at 37 °C for 7 days and exam-
ined daily for evidence of bacterial growth, including
turbidity and hemolysis. If bacterial growth was observed,
a subculture was made after 24 h on blood agar (CM0271,
Oxoid Ltd., England UK), Salmonella Shigella agar (SS)
(CM0099, Oxoid Ltd., England, UK), and MacConkey agar
(CM0007, Oxoid Ltd., England, UK).
Stool and fecal sludge culture
At the hospital, a swab of stool was inoculated into
45 ml buffered peptone water (CM0509 Oxoid Ltd.,
England, UK) and incubated at 37 °C for 18 h. In the la-
boratory, about 10 g fecal sludge sample from the public
toilets was inoculated with a sterile plastic spoon into
90 ml buffered peptone water and incubated at 37 °C for
18 h. Then, 0.1 ml of the overnight culture was trans-
ferred into 10 ml of Selenite F broth that was homoge-
nized and incubated at 37 °C for 18 h. Following
incubation, the sample was streaked onto SS agar and SSI
enteric media (Statens Serum Institute, Denmark) and in-
cubated for 18–24 h at 35–37 °C. Transparent colonies
with black centers on SS agar and cream colonies with
metallic sheen and a black center due to H2S produc-
tion on SSI enteric media were identified as presump-
tive Salmonella.
Biochemical identification, sero- and phage typing
All presumptive positive Salmonella isolates were subcul-
tured onto nutrient agar plates (CM0309; Oxoid Ltd.,
England, UK) and incubated at 37 °C for 16–18 h. Isolates
were first confirmed by their reaction in the Minibact-E
biochemical tests (SSI, Denmark) and then by slide
agglutination using polyvalent antisera (Poly A-E+Vi
from SSI, Denmark). Specific serovars were established byserotyping at the WHO National Salmonella and Shigella
Center, Institute of Health, Bangkok, Thailand [31].
Phage typing was done for S. Typhimurium (28 isolates)
and S. Enteritidis (43 isolates) according to the scheme de-
fined by the PHLS Colindale London at the OIE-National
reference laboratory for Salmonella, Istituto Zooprofilat-
tico Sperimentale delle Venezie, Italy [32]. Strains showing
a typing pattern that did not conform to any recognized
phage type was designated “reacted but did not conform”
(RDNC) while those that did not show any phage type
pattern at all were designated “non-typable” (NT).
Antimicrobial susceptibility testing
Antimicrobial susceptibility of Salmonella isolates was
determined by the agar disc diffusion method on Mueller-
Hinton agar (CM0337; Oxoid Ltd., England, UK) accord-
ing to the protocol and guidelines of the European
Committee on Antibiotic Susceptibility Testing (EUCAST).
Test were carried out in Ghana and repeated in Denmark
for quality assurance. The strains were screened for their
susceptibility to the following antimicrobials: ampicillin
(AMP, 10 μg), cefotaxime (CTX, 30 μg), cefoxitin (FOX,
10 μg), gentamicin (GEN, 10 μg), ceftazidime (CAZ, 30 μg),
amoxicillin clavulanic acid (AMC, 30 + 10 μg), tetracycline
(TET, 30 μg), chloramphenicol (CHL, 30 μg), trimethoprim
(TRI, 5 μg), sulfamethazole (SUL, 240 μg), nalidixic acid
(NAL, 30 μg), and ciprofloxacin (CIP, 5 μg) (ROSCO Diag-
nostic Neosensitabs, Denmark). E. coli ATCC 25922 and
Pseudomonas aeroginosa ATCC 27853 were used for qual-
ity control. The EUCAST breakpoints [33] were used to in-
terpret zone diameters.
Isolates that showed reduced susceptibility or resist-
ance to ceftazidime were further investigated for ESBL
phenotypes by a double disc diffusion test using the
cephalosporins CAZ, CTX, and FOX alone and in com-
bination with clavulanic acid. Interpretations were made
according to the EUCAST breakpoints [33].
PFGE
PFGE genotyping was done for the dominant Salmonella
serovars (52 strains of S. Enteritidis and 31 strains of S.
Typhimurium) of human origin to establish genetic het-
erogeneity within serovar. PFGE patterns were compared
with patterns previously described for S. Typhimurium
(N = 1) serovar isolated from poultry [32]. Overnight cul-
ture of Salmonella spp. grown in Luria-Bertani (LB)
broth (240230; Difco, MD, USA) was used to prepare
genomic DNA according to the CDC PulseNet protocol
[34] using 1% agarose (SeaKem ® gold agarose, Lonza,
Rockland, ME, USA). DNA embedded in the agarose
was digested with the restriction endonuclease XbaI
(R0145; New England BioLabs, Inc). The DNA frag-
ments were isolated by electrophoresis in 0.5× TBE buf-
fer using CHEF DR III (Bio-Rad Laboratories, Hercules,









S. Agona 1 1 (0.7)
S. Bredeney 1 1 2 (1.5)
S. Colindale 3 1 4 (2.9)
S. Derby 12 12 (8.8)
S. Dublin 3 2 5 (3.7)
S. Eastbourne 1 1 (0.7)
S. 4, 5, 12: i:- 1 1 2 (1.5)
S. 4, 12; -:1, 2 1 1 (0.7)
S. 9, 12: -:- 5 5 (3.7)
S. 8, 20: g, m:- 1 1 (0.7)
S. Enteritidis 1 4 9 40 54 (39.4)
S. Enugu 1 1 (0.7)
S. Ituri 1 1 2 (1.5)
S. Kaapstad 1 1 (0.7)
S. Oakland 1 1(0.7)
S. Oranienburg 1 1 (0.7)
S. Poona 2 2(1.5)
S. Senftenberg 1 1 (0.7)
S. Suberu 1 1 2 (1.5)
S. Typhimurium 2 3 18 10 33 (24.1)
S. Virchow 1 1 2 4 (2.9)
S. spp. (rough strain) 1 1 (0.7)
Total 13 26 35 63 137 (100)
aBlood and stool prospectively collected from patients at the two hospitals
bFecal sludge collected from public toilets in slum communities
cBlood and stool retrospectively collected from patients at the Korle Bu
teaching hospital
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final switch time of 54.4 s, current 6 V/cm, included angle
120, and run time of 19 h. Salmonella Braenderup was
used as the reference strain and a low range marker
(NO350S; New England BioLabs, Inc.) used as the size
marker. The gel was stained with 1% ethidium bromide
solution for 30 min and de-stained in deionized water for
30 min. The gel image was captured by GelDoc EQ sys-
tem with Quantity One® software (Version 4.2.1; Bio-Rad
Laboratories, Hercules, CA, USA).
Data analysis
All data were entered into spreadsheet of Microsoft
Excel 2010 and transferred to the statistical product for
service solution (SPSS) (version16, 2008) for Windows
which was used for descriptive analysis of data. Confi-
dence intervals (95% CI) for prevalence of Salmonella
strains found to be resistant to three or more antimicro-
bials were calculated as ρ ± z*square root of ((ρ*(1 − ρ)/n)
where ρ is the estimated prevalence, n is the population
size, and z = 1.96. Chi-square was used to test for differ-
ences in multi-resistant Salmonella proportion between
blood and stool samples using Minitab software. Phylo-
genetic analysis of PFGE patterns was done using Gel-
Compar® software (Version 4.6). The TIFF images were
normalized by aligning the peaks of the size standard
strain (S. Braenderup strain H9812) with the database
global standard. Cluster analysis was performed by un-
weighted pair group method of the PFGE patterns




All 137 strains were of Salmonella enterica and belonged
to 22 serovars with S. Enteritidis (39.4%), S. Typhimurium
(24.1%), and S. Derby (8.7%) as the most prevalent ones. S.
4, 5, 12: i: -, the monophasic variant of S. Typhimurium
and S. Senftenberg was also observed (Table 1). S.
Enteritidis and S. Typhimurium were more frequently
isolated from human blood than stool samples from
the hospitals, while S. Derby was the predominant
serovar from fecal sludge.
Phage typing of S. Enteritidis and S. Typhimurium
Forty-six S. Enteritidis and 28 S. Typhimurium strains
were phage typed. Forty-one percent (19/46) of S. Enter-
itidis strains reacted with phages but did not conform to
any definitive phage type (RDNC). Seven recognized
phage types were identified, with PT14B as the most
common (10/46) (Table 2). This phage type and PT4
were common phage types shown by both hospital isolates
and isolates obtained from fecal sludge samples. No com-
mon phage type was shared between the retrospectivehospital strain collection and the S. Enteritidis isolated
from the two hospitals during the current study.
S. Typhimurium included six strains reacting but not
conforming to any definitive phage type (RDNC), while
seven strains were non-typable (NT). The predominant
phage types were DT1, DT22, DT197, DT99, and DT120
(Table 2). DT197 was the only phage type common to
both hospital and fecal sludge isolates of S. Typhimurium.
DT22 was dominant among isolates collected from 2010
to 2011, while DT1 was the dominant phage type present
among the retrospective isolates (Table 2).
Antimicrobial susceptibility
Fifty-eight (42.3%) of the 137 Salmonella strains showed
multiple antimicrobial resistance (MAR), i.e., they were
resistant to three or more classes of antimicrobials, while
one of the Salmonella from fecal sludge showed MAR.
There was not one predominant resistance profile
Table 2 Phage type distribution of Salmonella Serovars
Enteritidis and Typhimurium
Sample types







PT1 2 1 3 (6.5)
PT4 1 1 2 4 (8.7)
PT4B 1 1 (2.2)
PT8 1 1 (2.2)
PT14B 2 8 10 (21.7)
PT14C 1 3 4 (8.7)
PT34 1 1 (2.2)
RDNC 1 18 19 (41.3)
NT 1 2 3 (6.5)
Total 1 4 5 36 46
S. Typhimurium
DT1 5 5 (17.9)
DT22 1 3 3 (10.7)
DT99 2 2 (7.1)
DT120 1 1 (3.6)
DT197 1 2 3 (10.7)
RDNC 1 4 1 6 (21.4)
NT 1 6 7 (25.0) 1
Total 2 2 15 9 28 2
aBlood and stool prospectively collected from patients at the two hospitals
bFecal sludge collected from public toilets in slum communities
cBlood and stool retrospectively collected from patients at the Korle Bu
teaching hospital
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majority of the resistant strains shared common resistance
pattern to AMP or TET (Table 3). Isolates showed low
prevalence of cephalosporin resistance with 8.0% resist-
ance to CAZ, 4.5% resistance to CTX, and 2.7% resistance
to FOX. All of the ceftazidime- and cefotaxime-resistant
isolates showed synergy with clavulanic acid indicating
possible ESBL phenotypes. Isolates also showed high-level
resistance to TMP (66.1%), SUL (46.4%), AMP (57.1%),
TET (61.6%), CHL (33.9%), CIP (25.0%), and NAL
(20.5%). MAR among isolates from blood (23/35) and
stool (5/14) obtained from hospitals did not differ sig-
nificantly (χ2 = 3.675, p = 0.055).
Among serovar S. Typhimurium, 19/33 (57.6%) were
MAR with low prevalence of resistance to AMC, CAZ,
CTX, and FOX and high resistance to TMP, SUL, CHL,
AMP, and TET. The remaining 14 strains were either
not resistant to any antimicrobial (4/33) or resistant to
at most three antimicrobial (10/33) (Table 3). In general,
S. Enteritidis strains showed the highest and most di-
verse resistance including 29/54 that were MAR. The
most common resistance patterns of this serovar wereAMP, TET, CHL, SUL, and TMP (6/29) and AMP, TET,
SUL, and TMP (5/29) (results not shown). Eleven out of
the 12 S. Derby strains isolated from public toilets
showed resistance to AMP and TET (Table 3).PFGE genotyping
PFGE typing of XbaI-digested chromosomal DNA of the
83 strains belonging to S. Typhimurium (n = 31) and S.
Enteritidis (n = 52) demonstrated that strains belonging
to the same serovar were typically either identical or
closely related with common band patterns irrespective
of the source of isolation. Cluster analysis of S. Enteritidis
strains showed wide genetic diversity with 25 PFGE types
based on a one-band difference. Among these PFGE types,
nine were represented by at least two strains clustering
with 100% similarity index, the rest of the profiles were
distinct (figure not shown). Cluster analysis of PFGE
patterns of S. Enteritidis strains from humans and those
from poultry (eight isolates) from a previous study [32]
showed the strains were closely related genetically with
two main clusters of 81.5% similarity (Fig. 1). Cluster I
consisted of six retrospective strains and one strain from
blood. Cluster II consisted of 20 strains of which 87.5% (7/
8) of the poultry strains clustered together at 100%
similarity index with strains from human sources while
other strains from blood, stool, and fecal sludge clustered
together or remained distinct with unique PFGE types. S.
Typhimurium showed 15 different PFGE types with 5 rep-
resented by at least 2 strains (X1, X4, X5, X10, and X11)
(Fig. 2). S. Typhimurium was not reported to be a com-
mon serovar among poultry isolates [32], and only one
poultry S. Typhimurium strain was available for com-
parison. This strain showed a unique PFGE type but
was 92.3% similar to a human strain (Fig. 2). Strains
from blood and stool clustered together or remained
unique irrespective of their source of isolation, phage
types, or antimicrobial resistance. No correlation was
observed between the phage types, antimicrobial resist-
ance patterns, and the PFGE types of the isolates tested
in this study.Discussion
Human salmonellosis is a major health problem in both
developing and developed countries across the globe.
NTS caused by salmonellae other than S. Typhi has been
the leading cause of secondary bacteremia associated
with gastroenteritis [8, 21]. We found 22 Salmonella ser-
ovars with S. Enteritidis and S. Typhimurium as the
most dominant among hospital isolates while S. Derby
was the most dominant serovar in fecal sludge. Gener-
ally, these serovars showed low resistance to cephalospo-
rins and high resistance to other antimicrobials routinely
used for therapeutic treatment of humans in Ghana.
Table 3 Antimicrobial resistance patterns of Salmonella serovars isolated from humans in Ghana
Serotype N Antimicrobialsa Summaryc
TET AMP AMX CIP NAL GEN TMP SUL CHL CAZ FOX CTX 0 1–3 >3
S. Enteritidis 54 32b 26 7 15 10 2 35 27 18 2 1 0 11 14 29
S. Typhimurium 33 11 16 3 5 3 1 17 12 11 2 2 2 4 10 19
S. Derby 12 11 11 0 1 0 0 0 0 0 0 0 0 1 11 0
S. Dublin 5 0 1 1 1 0 0 3 1 0 1 0 0 1 4 0
S. 9,12:-:- 5 4 3 0 1 1 0 4 4 3 0 0 0 1 1 3
S. Virchow 4 0 2 1 1 2 0 2 1 0 2 0 2 0 4 0
S. Colindale 4 1 1 1 0 1 0 2 0 0 1 0 0 2 1 1
S. Bredeney 2 1 0 0 0 0 0 1 1 1 0 0 0 1 0 1
S. 4,5,12:i:- 2 1 1 0 0 0 0 1 1 1 0 0 0 1 0 1
S. Poona 2 1 1 1 1 1 0 2 1 1 1 0 1 0 1 1
S. Ituri 2 1 0 0 0 1 0 1 1 1 0 0 0 0 1 1
S. Suberu 2 2 0 0 2 1 0 1 1 1 0 0 0 0 1 1
S. Agona 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0
S. Eastborne 1 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0
S. 4,12:-:1,2 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
S. 8,20:g,m:- 1 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0
S. Enugu 1 0 0 0 0 1 0 1 1 0 0 0 0 0 1 0
S. Oakland 1 1 0 0 0 0 0 1 1 1 0 0 0 0 0 1
S. Oranienburg 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
S. Senftenberg 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
S. Kapstaad 1 1 0 0 1 0 0 1 0 0 0 0 0 0 1 0
Salmonella spp. (rough strains) 1 1 1 0 0 0 1 0 0 0 0 0 0 0 1 0
Total 137 69 64 14 28 23 4 74 52 38 9 3 5 25 54 58
aTET tetracycline, AMP ampicillin, CIP ciprofloxacin, NAL nalidixic acid, GEN gentamicin, TMP trimethoprim, SUL sulfamethazole, CHL chloramphenicol, AMX
amoxicillin clavulanic acid, CAZ ceftazidime, CTX cefotaxime, FOX cefoxitin
bNumbers under the different antimicrobials indicate the number of resistant isolates
c0 = susceptible to all tested antimicrobials, 1–3 = resistant up to three antimicrobials, >3 =multiresistant to more than three classes of antimicrobials
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Enteritidis and S. Typhimurium as the major serovars
found in humans [35, 36]. In Ghana and most other
African countries, they are also the most frequently
isolated from bloodstream infections [7, 8, 21, 37] and
from diarrheal diseases [38], which is confirmed by the
findings of the present study. We report a low (8.0%
CAZ, 4.5% CTX, and 2.7% FOX) cephalosporin resist-
ance but high resistance to other antimicrobials among
Salmonella strains, which calls for implementation of
national surveillance systems of antimicrobial resistance
and implementation of prudent antimicrobial usage,
including revision of current national guidelines for anti-
microbial usage due to the risk of resistance.
High-level cephalosporin resistance has been reported in
Salmonella isolates from humans in countries like Malaysia
[20], United States of America (USA) [39, 40], Jamaica
[41], and Canada [42]. In Africa, high resistance has been
reported to cephalosporins in Morocco [43], but on the
other hand, low resistance has been reported in BurkinaFaso [38]. A previous study in Ghana has reported no
cephalosporin resistance in poultry from poultry farms and
at poultry slaughter areas [32], since cephalosporins are
not yet reportedly used in poultry production.
Over the years, ampicillin, chloramphenicol, and cotri-
moxazole (trimethoprim/sulfamethoxazole) were first-
line antimicrobials for treatment of severe salmonellosis
[1, 44], but in developing countries like Ghana, chloram-
phenicol, fluoroquinolone, or third-generation cephalo-
sporins are now commonly used as ampicillin, and
cotrimoxazole have become ineffective due to develop-
ment of resistance [25, 45]. Our susceptibility testing
indicates moderate resistance to chloramphenicol (33.9%)
and fluoroquinolones (25.0%), which means that although
they are still a useful choice for empirical treatment of
blood stream infections with Salmonella in Ghana,
care must be taken to maintain or minimize increase
in resistance.
S. Typhimurium has often been associated with mul-
tiple antimicrobial resistances [46] partly due to the
Fig. 1 Dendrogram of cluster analysis of S. Enteritidis strains from human (B/S, blood, stool, and fecal sludge) and poultry (feces and dust) generated
with gel Compar Software using unweighted pair-group arithmetic means (UPGMA) methods with 2.0% band position tolerance and
0.50% optimization parameter. n = not determined
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Fig. 2 Dendrogram of cluster analysis of S. Typhimurium strains from human (B/S, blood, stool, and fecal sludge) and poultry generated with gel
Compar Software using unweighted pair-group arithmetic means (UPGMA) methods with 2.0% band position tolerance and 0.50% optimization
parameter. n = not determined
Andoh et al. Tropical Medicine and Health  (2017) 45:3 Page 8 of 11
Andoh et al. Tropical Medicine and Health  (2017) 45:3 Page 9 of 11emergence of S. Typhimurium definitive phage type (DT)
104 worldwide. Strains of this phage type are resistant to
ampicillin, chloramphenicol, streptomycin, sulfonamides,
and tetracycline [47]. Although S. Typhimurium DT 104
was not identified in this study, other phage types identi-
fied also showed high resistance to ampicillin, chloram-
phenicol, trimethoprim, and sulfonamides. It is interesting
to note that most of the S. Enteritidis and S. Typhimurium
strains were either RDNC or non-typeable by the phage
typing system used, which indicates that new or undocu-
mented phage types are emerging in developing countries
and that such types can cause infections in humans. In
this respect, previous reports that phage types of S.
Enteritidis [48] may change as a result of acquisition of R-
plasmids may be important, implying that selection for
multiple antimicrobial resistant strains may change phage
type distribution. PT14B, PT4, and PT1 were the domin-
ant recognized phage types of S. Enteritidis, but with a
time-dependent distribution. This picture of succession in
dominance by particular phage types are also seen in other
geographical regions. Point estimates of phage type
distribution often show dominance of one type of S.
Enteritidis, PT 29 in Nigeria, PT4 in England, PT6 in
Denmark, PT8 in Poland, PT1 in Russia, and PT8 and
PT13a in USA [49], but over time, they spread to other
regions possibly due to trade and travel and are no longer
so dominant. S. Typhimurium DT1 was previously identi-
fied as the dominant phage type in humans in Kenya [50],
and apparently, this type is still highly prevalent, indicating
a stable source for possible spill over to other humans.
Feglo et al. [51] reported a 2.3% Salmonella carriage
among 258 healthy food handlers in Kumasi. Many food
handlers and consumers, but also other people, use the
public toilets [13]. Thus, the collection and analysis of fecal
sludge from public toilets is a cost-effective and seemingly
convenient and sensitive method to isolate Salmonella
from human carriers with unknown disease status.
It is well recognized that antimicrobial-resistant
Salmonella in poultry and other food products translate
into resistance of Salmonella in humans. In order to
investigate the role of poultry as a source for human NTS
in Ghana, PFGE molecular typing analysis was done. PFGE
has a high discriminatory power and is therefore often used
in characterizing isolates from different sources in epi-
demiological studies of disease outbreaks [27, 52]. The
similar PFGE band patterns generated in this current study
among S. Enteritidis and S. Typhimurium (although just
one isolate) indicate that poultry could be a likely source of
Salmonella in humans in Ghana. The current study lacks
parallelism between sampling in poultry and in hospitals,
while concurrent sampling was performed in poultry and
in public toilets in the same geographic region. Based
on the overall lack of similarity in strains obtained
from poultry and toilets, it seems fair to conclude thatpoultry most likely is far from the only source linked to
human infections in Ghana. The most common Salmonella
serovar found in poultry was Salmonella Kentucky [32];
however, this serovar was not observed among human
isolates in our study although it has been reported earlier in
humans in neighboring Burkina Faso [38]. This corre-
sponds well with reports from other countries, USA for
example, where S. Kentucky is also common in poultry, but
very rarely causes human disease [53]. This lack of
agreement between S. Kentucky prevalence in poultry and
disease incidence in humans has been attributed to the
distribution of some phage-associated virulence genes and
virulence plasmids in S. enterica serovars [54]. Poultry
associated S. Kentucky persists in poultry due to its
metabolic adaptation to the chicken cecum but shows low
virulence to humans, a situation that would be similar to
what has been documented for the serovar Tennessee in
Denmark [55]. Since the chain from poultry to humans is
very short in Ghana, often consisting of just a slaughter
process at local markets, the most likely explanation is that
the poultry strain of S. Kentucky in Ghana is possibly
of low virulence. The identical PFGE band patterns
among the isolates of serovar Typhimurium and
Enteritidis from humans (hospital and fecal sludge)
indicate one or more common sources of exposure, e.g.,
food and water, which is not yet identified. Salmonella
may even be transmitted directly from humans to
humans, given the poor sanitary conditions in urban and
peri-urban areas of Ghana. Thus, proper surveillance of
all food animals and their products as well as humans
for Salmonella is highly needed together with assess-
ment of epidemiological risk factors associated with
human salmonellosis.
The unsystematic and extensive use of antimicrobials in
animal and human medicine has increased the emergence
and spread of multiple antimicrobial-resistant bacterial
pathogens. There is therefore an urgent need to establish
a surveillance of possible circulating ESBL-producing and
fluoroquinolone-resistant Salmonella in Ghana to ensure
cautious use of antimicrobials in both human and animals.
The genetic relationship between NTS isolated from
humans (blood, stool, and fecal sludge) and poultry and
the high prevalence of resistance to routine antimicrobials
including fluoroquinolones as well as the seemingly low
cephalosporin resistance observed in this study suggest
that future studies should look more into NTS as causes
of blood infections in Ghana. Sources and ways of trans-
mission of antimicrobial resistance and MAR among NTS
should be continuously monitored, e.g., in national micro-
biological and epidemiological surveillance programs.
Conclusions
Possibly due to the unsystematic and extensive use of
antimicrobials in animal and human, the level of
Andoh et al. Tropical Medicine and Health  (2017) 45:3 Page 10 of 11multiple antimicrobial resistance in NTS in Ghana is
high. There is therefore an urgent need to establish a
surveillance of resistance in Salmonella in Ghana to as-
sist in recommendations on the use of antimicrobials in
both human and animals. The genetic relationship be-
tween NTS isolated from humans (blood, stool, and
fecal sludge) and poultry and their high prevalence of re-
sistance to routine antimicrobials including fluoroquino-
lones suggest that resistant NTS could be an important
emerging public health threat in Ghana, e.g., as causes
of blood infections. Sources and ways of transmission of
antimicrobial resistance and MAR among NTS should
be continuously monitored, e.g., in national microbio-
logical and epidemiological surveillance programs.
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